Literature DB >> 14035436

Procaine (novocain) treatment of patients with senile and arteriosclerotic brain disease.

V A KRAL, C CAHN, M DEUTSCH, H MUELLER, L SOLYOM.   

Abstract

Of 32 patients (13 men and 19 women) with a mean age of 81.1 years committed to a mental hospital for senile or arteriosclerotic psychoses, 11 received 2% procaine hydrochloride according to Aslan's method, for an average of 13 months, 11 for 6 months, and 10 normal saline. Of 20 patients, with a mean age of 72 years, who attended the geriatric psychiatric clinic of a general hospital, 10 were treated with procaine hydrochloride and 10 with normal saline for six months. Procaine hydrochloride applied for six or 12 months did not appreciably alter the symptomatology and course of senile and arteriosclerotic brain disease. It did not improve the senile amnestic syndrome or neurological symptomatology, when present. The general mood and level of activity improved temporarily. It was also temporarily helpful in alleviating depressive symptoms in patients suffering from arteriosclerotic brain disease.

Entities:  

Keywords:  CEREBRAL ARTERIOSCLEROSIS; PROCAINE; PSYCHOSES, SENILE

Mesh:

Substances:

Year:  1962        PMID: 14035436      PMCID: PMC1849821     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  Trial of procaine in old age and chronic degenerative disorders.

Authors:  J A BERRYMAN; H A FORBES; R SIMPSON-WHITE
Journal:  Br Med J       Date:  1961-12-23

2.  Trial of procaine in the aged.

Authors:  S R FEE; A N CLARK
Journal:  Br Med J       Date:  1961-12-23

3.  A clinical trial of procaine hydrochloride.

Authors:  J HIRSH
Journal:  Br Med J       Date:  1961-12-23

4.  Effects of ribonucleic aid on memory.

Authors:  D E CAMERON; L SOLYOM
Journal:  Geriatrics       Date:  1961-02

5.  A comparative study of the amnestic syndrome in various organic conditions.

Authors:  V A KRAL; H B DUROST
Journal:  Am J Psychiatry       Date:  1953-07       Impact factor: 18.112

6.  A psychopharmacological evaluation of 2-diethylaminoethyl-para-aminobenzoate (procaine).

Authors:  L BUCCI; J C SAUNDERS
Journal:  J Neuropsychiatr       Date:  1960 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.